Dharamshila Hospital Organized A Live Workshop on Composite Resection with Micro vascular Free Fibular Flap reconstruction
According to Dr. S. Khanna, Executive Director, Dharamshila Hospital And Research Centre “Most cases of Head and Neck cancers are diagnosed at stage III and stage IVA. Head and neck Cancer Surgeries require complex infrastructure with a dedicated team. Due to lack of desired infrastructure, even now most of the Head and Neck surgeries are not being performed anywhere in North India. She also said that Dharamshila Hospital is performing 180 – 200 free flap reconstructions per annum which is the highest figure in India and offers more than 96% success rate. The credit for such high success rate goes to the team work of our dedicated and focused Head and Neck Surgical Oncologists, Plastic Surgeons, Anaesthesiologists, Critical care experts, Radiation Oncologists, Medical Oncologists, Onco-pathologists, Imaging Experts, Physiotherapists, Critical Care Nurses, technicians, Prosthodontics , speech therapist and high-end diagnostic, prognostic and therapeutic technologies”.
Dr. Anshuman Kumar and Dr. Mudit Agarwal, Head and Neck Surgical Oncologist demonstrated and explained the steps of composit resection of the cancerous tissues ensuring clear margins and removing all lymph nodes. After removal of the cancerous tissues, a large gap appeared which, was reconstructed by the plastic surgeons using microvascular flap from leg for jaw reconstruction by Dr. Ehsaan Siddiqui and Dr. Anshuman Kumar.
Dr. Anshuman Kumar explained that the objective of this high risk and challenging surgery is to ensure that patient is cancer free, gets close to normal appearances with restoration of eating, swallowing and voice. The august gathering of participants included Surgical Oncologists, Facio-maxillary surgeons, Dental surgeons, ENT surgeons etc. During Surgery, participants were interacting actively with the Operating team and the moderator.
This was followed by a video of a patient, who had fully recovered from this surgery and shared his experience during treatment at DHRC. Afternoon session on video workshop was conducted by Dr. Mudit Agarwal. He showed videos of Co2 laser surgeries for organ and function preservation for early cancers of vocal cord and larynx (voice box). He also explained the advantages of endoscopic Co2 laser resection, where there is no external cut and surgery is done from inside the mouth. The major advantage of the procedure is that patient can be discharged next day and resumes work within few days. This procedure has minimal side effects with good voice preservation. Co2 laser surgeries at Dharamshila Hospital are a boon for patients of North India. If Co2 laser surgery is not possible, voice conservation open surgeries are performed, preserving the voice of a person.
About Dharamshila Hospital AND Research Center
Dharamshila Hospital And Research (DHRC), one of the largest Cancer Hospitals in India and IS recognized as the first and only cancer hospital of India, accredited by National Accreditation Board for Hospitals and Healthcare Providers (NABH), was established on 19 April 1990. Promoted by Dharamshila Cancer Foundation and Research Centre (DCFRC), DHRC was established with the sole aim of providing comprehensive cancer care to cancer patients and make cancer treatment available, accessible and affordable.
The first phase of Dharamshila Hospital and Research Centre (DHRC) with 100 beds was commissioned in 1994 and expanded to 300 beds in 2008. The hospital, today, has evolved into North India's premier cancer institute, treating all types of cancers.
Dharamshila Hospital and Research Centre
Dharamshila Marg, Vasundhara Enclave
Delhi - 110096, INDIA
Tel: 011 - 43066353
Fax: 011 - 22617770 / 22619033 / 22618574
Email: email@example.com , firstname.lastname@example.org
Website : http://www.dhrc.in
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dharamshila Hospital Organized A Live Workshop on Composite Resection with Micro vascular Free Fibular Flap reconstruction here
News-ID: 220666 • Views: 1690
More Releases from Dharamshila Hospital and Research Centre
Haplo-Identical Bone Marrow Transplantation, “The Glass is Always Half Full”
A 25 year old IT professional was struck with Hodgkin ’s disease which is one of the most curable cancers. He was treated with standard chemotherapy and the disease went away only to reappear a few months later. This time he received local radiation and Autologous Bone Marrow Transplantation (BMT). However, the response was shortlived and the cancer sprung its ugly head within 6 months. The young man and his distraught
Most Promising Healthcare Chain 2014 for Dharamshila Hospital & Research Centre
Eminent Healthcare Expert Dr Sandeep Chatrath receives the prestigious India’s Most Promising Healthcare Chain 2014 for Dharamshila Hospital & Research Centre ILc Power Brand 2014. Dr Sandeep Chatrath also declared by the Jury as the CEO of the Year Healthcare 2014 at Asia’s Biggest Leadership Event, the 5th Annual India Leadership Conclave 2014 The prestigious & coveted Awards were presented in a glittering award ceremony
Dharamshila Hospital Urges To Join Hands To Fight Against Cancer In Children
New Delhi, June 21, 2012: Childhood cancer contributes to nearly 5% of the total cancer burden in India, with approximately 45,000 children diagnosed with cancer every year. As increasing prevalence of cancer among children is becoming a cause of great concern, there is an urgent need to spread awareness about childhood cancers, for timely detection and treatment, say doctors at Dharamshila Hospital and Research Centre, India’s first and only NABH
Dharamshila Hospital start its Cancer OPD in Patna, Bihar at Ford Hospital to ca …
New Delhi, Feburary 1, 2012 Dharamshila Hospital And Research Centre, India’s first and only NABH accredited Cancer Hospital, going to start its Cancer OPD in Bihar at Ford Hospital And Research Centre, Patna on 4th and 5th Feburary 2012. Bihar has recorded an alarming rise in the incidence of cancer with an estimated 200,000 people suffering from this killer disease. Lack of awareness among the people about the disease coupled
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and